Abstract
Relapsing polychondritis, or RP, is a rare connective tissue disease characterized by relapsing-remitting destructive inflammation of the cartilaginous and other proteoglycan-rich structures in the body. Given the relatively low incidence of RP, a concise clinically relevant guide, focusing on the cutaneous manifestations of this serious disease, is lacking. In this review, we provide the dermatologist with an approach to diagnosing RP and a guide to its initial work-up, and management. We close with an overview of the currently available treatment modalities for RP.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 77-86 |
| Number of pages | 10 |
| Journal | American Journal of Clinical Dermatology |
| Volume | 18 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2017 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Relapsing Polychondritis : A Review and Guide for the Dermatologist. / Smylie, A. L.; Malhotra, Neel; Brassard, Alain.
In: American Journal of Clinical Dermatology, Vol. 18, No. 1, 01.02.2017, p. 77-86.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Relapsing Polychondritis
T2 - A Review and Guide for the Dermatologist
AU - Smylie, A. L.
AU - Malhotra, Neel
AU - Brassard, Alain
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Relapsing polychondritis, or RP, is a rare connective tissue disease characterized by relapsing-remitting destructive inflammation of the cartilaginous and other proteoglycan-rich structures in the body. Given the relatively low incidence of RP, a concise clinically relevant guide, focusing on the cutaneous manifestations of this serious disease, is lacking. In this review, we provide the dermatologist with an approach to diagnosing RP and a guide to its initial work-up, and management. We close with an overview of the currently available treatment modalities for RP.
AB - Relapsing polychondritis, or RP, is a rare connective tissue disease characterized by relapsing-remitting destructive inflammation of the cartilaginous and other proteoglycan-rich structures in the body. Given the relatively low incidence of RP, a concise clinically relevant guide, focusing on the cutaneous manifestations of this serious disease, is lacking. In this review, we provide the dermatologist with an approach to diagnosing RP and a guide to its initial work-up, and management. We close with an overview of the currently available treatment modalities for RP.
UR - http://www.scopus.com/inward/record.url?scp=85011914092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011914092&partnerID=8YFLogxK
U2 - 10.1007/s40257-016-0226-0
DO - 10.1007/s40257-016-0226-0
M3 - Review article
VL - 18
SP - 77
EP - 86
JO - American Journal of Clinical Dermatology
JF - American Journal of Clinical Dermatology
SN - 1175-0561
IS - 1
ER -